• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: EDWARDS LIFESCIENCES EDWARDS INSPIRIS RESILIA AORTIC VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

EDWARDS LIFESCIENCES EDWARDS INSPIRIS RESILIA AORTIC VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE Back to Search Results
Model Number 11500A
Device Problem Calcified (1077)
Patient Problems Dyspnea (1816); Insufficient Information (4580)
Event Type  Injury  
Manufacturer Narrative
Attempts to retrieve the device and additional information are in process.The investigation is still in progress; therefore, a conclusion has yet to be established.A supplemental report will be submitted accordingly upon investigation completion.Edwards will continue to review and monitor all reported events.Trends are monitored on a monthly basis and if action is required, appropriate investigation will be performed.
 
Event Description
Edwards received notification that this valve model 11500a21 implanted in aortic position was explanted from a 65-year-old patient after an unknown implant duration, however no longer than six (6) years and one (1) month due to calcific degeneration affecting the three leaflets, and mild pannus under the ring.Another bioprosthetic valve was implanted in replacement.Unfortunately, patient passed away few days after redo procedure due to a stroke.The cause of death was not imputed to the edwards device, but to carotid stenosis.As reported, this affection had not been previously identified.
 
Manufacturer Narrative
H3: evaluation summary: customer report of calcification, pannus and stenosis were confirmed.X-ray demonstrated commissures 1 and 2 were bent outwards and cocr band intact; the vfit cocr alloy band was not expanded.Heavy calcification was observed on leaflets 2 and 3, and minimal calcification on leaflet 1.Extrinsic calcific deposits were observed on the inflow and outflow surfaces of leaflets 2 and 3.Minimal host tissue overgrowth encroached onto the leaflet and into the orifice at the greatest distance of approximately 3mm on leaflet 2 on the inflow aspect.Host tissue on the stent circumference was minimal at the inflow aspect.Calcification restricted leaflet mobility and led to stenosis.Multiple suture holes were observed around the sewing ring.The investigation is still in progress; therefore, a conclusion has yet to be established.A supplemental report will be submitted accordingly upon investigation completion.Edwards will continue to review and monitor all reported events.Trends are monitored on a monthly basis and if action is required, appropriate investigation will be performed.
 
Event Description
Edwards received notification that this valve model 11500a21 implanted in aortic position was explanted from a 65-year-old patient after an implant duration of six (6) years and (28) twenty-eight days due to calcific degeneration affecting the three leaflets, and mild pannus under the ring leading to stenosis (mean gradient of 59mmhg).As reported, patient presented with dyspnea.Another bioprosthetic valve was implanted in replacement.Unfortunately, patient passed away few days after redo procedure due to a stroke.The cause of death was not imputed to the edwards device, but to carotid stenosis.As reported, this affection had not been previously identified.As per medical records, patient had a recurrent epilepsy seizure after surgery and a medical treatment was indicated.An angiography of supra aortic arteries showed a 70 % stenosis (nascet criteria) of the right carotid at the level of the carotid bulb and a 75 % stenosis at the origin of the left subclavian artery.A ct scan on # pod 2, showed a massive right ischemic mca stroke with cerebral edema and mass effect.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EDWARDS INSPIRIS RESILIA AORTIC VALVE
Type of Device
HEART-VALVE, NON-ALLOGRAFT TISSUE
Manufacturer (Section D)
EDWARDS LIFESCIENCES
one edwards way
irvine CA 92614
Manufacturer (Section G)
EDWARDS LIFESCIENCES
one edwards way
irvine CA 92614
Manufacturer Contact
saurav singh
one edwards way
mle fl2 office m2013
irvine, CA 92614
9492506615
MDR Report Key19125773
MDR Text Key340448420
Report Number2015691-2024-02913
Device Sequence Number1
Product Code LWR
UDI-Device Identifier00690103194975
UDI-Public(01)00690103194975(17)190525
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P150048
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 05/13/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date05/25/2019
Device Model Number11500A
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 03/27/2024
Initial Date FDA Received04/17/2024
Supplement Dates Manufacturer Received04/17/2024
Supplement Dates FDA Received05/13/2024
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured05/25/2017
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention; Life Threatening; Hospitalization;
Patient Age65 YR
Patient SexFemale
Patient Weight78 KG
-
-